A Phase 2 Clinical Study of CU-20401

Clinical trial NCT06194188 · COMPLETED

Trial details

NCT number: NCT06194188
Sponsor: Cutia Therapeutics（Wuxi）Co.,Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Efficacy and Safety

Start date: 2023-12-20
Primary completion: 2024-09-02
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.